Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 16:05 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
November 29, 2023 06:59 ET
|
Generation Bio Co.
Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell typesDevelopment of immune-quiet DNA (iqDNA)...
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
November 09, 2023 16:15 ET
|
Generation Bio Co.
- Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics - Proprietary cell-targeted LNP delivery system...
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
October 26, 2023 06:59 ET
|
Generation Bio Co.
70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle...
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
October 18, 2023 06:59 ET
|
Generation Bio Co.
– Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with a systemic cytokine profile and...
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
September 19, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 03, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Second Quarter 2023 Financial Results
August 02, 2023 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
May 31, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
May 10, 2023 16:15 ET
|
Generation Bio Co.
Company entered into strategic collaboration with Moderna to use Generation Bio’s proprietary non-viral genetic medicine delivery system for two liver disease programs and to co-develop novel...